Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Gastrointestinal Medicine
Volume 2011, Article ID 758947, 3 pages
http://dx.doi.org/10.1155/2011/758947
Case Report

Arsenic-Induced Pancreatitis

Division of Gastroenterology, West Penn Allegheny Health System, 1307 Federal Street, Suite 301, Pittsburgh, PA 15212, USA

Received 16 June 2011; Accepted 10 July 2011

Academic Editors: R. Kochhar and F. H. Mourad

Copyright © 2011 Sean Connelly et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. K. Hillestad, “Acute promyelocytic leukemia,” Acta Medica Scandinavica, vol. 159, no. 3, pp. 189–194, 1957. View at Google Scholar · View at Scopus
  2. S. L. Soignet, P. Maslak, Z. G. Wang et al., “Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide,” New England Journal of Medicine, vol. 339, no. 19, pp. 1341–1348, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. R. P. Warrell Jr., H. de The, Z. Y. Wang, and L. Degos, “Acute promyelocytic leukemia,” New England Journal of Medicine, vol. 329, no. 3, pp. 177–189, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. M. S. Tallman, C. Nabhan, J. H. Feusner, and J. M. Rowe, “Acute promyelocytic leukemia: evolving therapeutic strategies,” Blood, vol. 99, no. 3, pp. 759–767, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Tallman and J. K. Altman, “Curative strategies in acute promyelocytic leukemia,” Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, pp. 391–399, 2008. View at Google Scholar · View at Scopus
  6. E. Fox, B. I. Razzouk, B. C. Widemann et al., “Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma,” Blood, vol. 111, no. 2, pp. 566–573, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. B. Katzung, “Arsenic,” in Basic and Clinical Pharmacology, p. 949, McGraw-Hill, New York, NY, USA, 2007. View at Google Scholar
  8. T. D. Zhang, G. Q. Chen, Z. G. Wang, Z. Y. Wang, S. J. Chen, and Z. Chen, “Arsenic trioxide, a therapeutic agent for APL,” Oncogene, vol. 20, no. 49, pp. 7146–7153, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. G. Q. Chen, X. G. Shi, W. Tang et al., “Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells,” Blood, vol. 89, no. 9, pp. 3345–3353, 1997. View at Google Scholar · View at Scopus
  10. J. Zhu, M. H. M. Koken, F. Quignon et al., “Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 3978–3983, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Shao, M. Fanelli, F. F. Ferrara et al., “Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells,” Journal of the National Cancer Institute, vol. 90, no. 2, pp. 124–133, 1998. View at Google Scholar · View at Scopus
  12. Y. Jing, J. Dai, R. M. E. Chalmers-Redman, W. G. Tatton, and S. Waxman, “Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway,” Blood, vol. 94, no. 6, pp. 2102–2111, 1999. View at Google Scholar · View at Scopus
  13. L. Liu, J. R. Trimarchi, P. Navarro, M. A. Blasco, and D. L. Keefe, “Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis,” Journal of Biological Chemistry, vol. 278, no. 34, pp. 31998–32004, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. W. C. Chou, C. Jie, A. A. Kenedy, R. J. Jones, M. A. Trush, and C. V. Dang, “Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 13, pp. 4578–4583, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. C. Huang, W. Y. Ma, J. Li, and Z. Dong, “Arsenic induces apoptosis through a c-Jun NH2-terminal kinase- dependent, p53-independent pathway,” Cancer Research, vol. 59, no. 13, pp. 3053–3058, 1999. View at Google Scholar · View at Scopus
  16. K. Davison, K. K. Mann, S. Waxman, and W. H. Miller Jr., “JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells,” Blood, vol. 103, no. 9, pp. 3496–3502, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. S. Mukherjee, D. Das, S. Darbar, M. Mukherjee, A. S. Das, and C. Mitra, “Arsenic trioxide generates oxidative stress and islet cell toxicity in rabbit,” Current Science, vol. 86, no. 6, pp. 854–857, 2004. View at Google Scholar · View at Scopus
  18. G. P. Zaloga, J. Deal, T. Spurling et al., “Unusual manifestations of arsenic intoxication,” American Journal of the Medical Sciences, vol. 289, no. 5, pp. 210–214, 1985. View at Google Scholar · View at Scopus
  19. R. N. Ratnaike, “Acute and chronic arsenic toxicity,” Postgraduate Medical Journal, vol. 79, no. 933, pp. 391–396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Yamano, T. Yokote, T. Akioka et al., “Acute pancreatitis during the treatment of relapsed acute promyelocytic leukemia with As2O3,” Rinsho Ketsueki, vol. 47, no. 1, pp. 23–25, 2006. View at Google Scholar · View at Scopus
  21. P. Hantson, V. Haufroid, J. P. Buchet, and P. Mahieu, “Acute arsenic poisoning treated by intravenous dimercaptosuccinic acid (DMSA) and combined extrarenal epuration techniques,” Journal of Toxicology—Clinical Toxicology, vol. 41, no. 1, pp. 1–6, 2003. View at Publisher · View at Google Scholar · View at Scopus